Interferon-γ-Stimulated Human Keratinocytes Express the Genes Necessary for the Production of Peptide-Loaded MHC Class II Molecules

Journal of Investigative Dermatology - Tập 110 - Trang 138-142 - 1998
Cristina Albanesi andrea Cavani1, Giampiero Girolomoni1
1Laboratory of Immunology, Istituto Dermopatico dell'Immacolata, IRCCS, Rome, Italy

Tài liệu tham khảo

Aubӧck, 1986, HLA-DR expression on keratinocytes is a common feature of diseased skin, Br J Dermatol, 115, 465, 10.1111/j.1365-2133.1986.tb02851.x Bal, 1990, Antigen presentation by keratinocytes induces tolerance in human T cells, Eur J Immunol, 20, 1893, 10.1002/eji.1830200904 Basham, 1984, Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes, J Invest Dermatol, 83, 88, 10.1111/1523-1747.ep12262597 Basham, 1985, Recombinant gamma interferon differentially regulates class II antigen expression and biosynthesis on cultured human keratinocytes, J Interferon Res, 5, 23, 10.1089/jir.1985.5.23 Chang, 1994, Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes, J Exp Med, 180, 1367, 10.1084/jem.180.4.1367 Chang, 1996, Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression, Immunity, 4, 167, 10.1016/S1074-7613(00)80681-0 Cresswell, 1996, Invariant chain structure and MHC class II function, Cell, 84, 505, 10.1016/S0092-8674(00)81025-9 Dubey, 1996, Naive and effector CD4T cells differ in their requirements for T cell receptor vs. costimulatory signals, J Immunol, 157, 3280, 10.4049/jimmunol.157.8.3280 Feinberg, 1983, A technique for radiolabeling DNA restriction fragments to high specific activity, Anal Biochem, 132, 6, 10.1016/0003-2697(83)90418-9 Fineschi, 1996, The proteolytic enviroment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain, J Immunol, 157, 3211, 10.4049/jimmunol.157.8.3211 Fung-Leung, 1996, Antigen presentation and T cell development in H2-M-deficient mice, Science, 271, 1278, 10.1126/science.271.5253.1278 Gaspari, 1988, Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes, J Immunol, 140, 2956, 10.4049/jimmunol.140.9.2956 Gaspari, 1988, Class II MHC-bearing keratinocytes induce antigen- specific unresponsiveness in hapten-specific Th1 clones, J Immunol, 141, 2216, 10.4049/jimmunol.141.7.2216 Gaspari, 1993, Accessory and alloantigen- presenting cell functions of A431 keratinocytes that stably express the B7 antigen, Cell Immuno, 149, 291, 10.1006/cimm.1993.1156 Girolomoni, 1993, Prolactin stimulates proliferation of cultured human keratinocytes, J Invest Dermatol, 101, 275, 10.1111/1523-1747.ep12365203 Green, 1995, The intracellular transport of MHC class II molecules in the absence of HLA-DM, J Immunol, 155, 3759, 10.4049/jimmunol.155.8.3759 Kämpgen, 1991, Class II MHC molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down regulated upon culture, Proc Natl Acad Sci USA, 88, 3014, 10.1073/pnas.88.8.3014 Karlsson, 1994, Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells, Science, 266, 1569, 10.1126/science.7985028 Kelly, 1991, MonacoJJ, Cho S, Trowsdale J: A new human HLA class II-related locus, DM. Nature, 353, 571, 10.1038/353571a0 Kropshofer, 1995, Self-release of CLIP in peptide loading of HLA-DR molecules, Science, 270, 1357, 10.1126/science.270.5240.1357 Kropshofer, 1997, How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest, Immunol Today, 18, 77, 10.1016/S0167-5699(97)01006-2 Martin, 1996, H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection, Cell, 84, 543, 10.1016/S0092-8674(00)81030-2 Mellins, 1990, Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes, Nature, 343, 71, 10.1038/343071a0 Mommaas, 1995, Distribution of HLA-class II molecules in epidermal Langerhans cells in situ, Eur J Immunol, 25, 520, 10.1002/eji.1830250232 Mutis, 1993, HLA Class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells, Scand J Immunol, 37, 43, 10.1111/j.1365-3083.1993.tb01663.x Nickoloff, 1994, Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes, Immunol Today, 15, 464, 10.1016/0167-5699(94)90190-2 Nickoloff, 1993, Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated-1/Intercellular adhesion molecule-1 interaction, J Immunol, 150, 2148, 10.4049/jimmunol.150.6.2148 Nickoloff, 1993, Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo, Am J Pathol, 142, 1029 Nickoloff, 1986, Human keratinocyte- lymphocyte reactions in vitro, J Invest Dermatol, 87, 11, 10.1111/1523-1747.ep12523513 Niederwieser, 1988, TroppmaierJ, et al: IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses, J Immunol, 140, 2556, 10.4049/jimmunol.140.8.2556 Pieters, 1997, MHC class II restricted antigen presentation, Curr Op Immunol, 9, 89, 10.1016/S0952-7915(97)80164-1 Reith, 1995, Molecular defects in the bare lymphocyte syndrome and regulation of MHC Class II genes, Immunol Today, 16, 539, 10.1016/0167-5699(95)80048-4 Roche, 1991, Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain, Nature, 354, 392, 10.1038/354392a0 Sadegh-Nasseri, 1991, A role for peptide in determining MHC class II structure, Nature, 353, 167, 10.1038/353167a0 Sanderson, 1994, Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments, Science, 266, 1566, 10.1126/science.7985027 Stallcup, 1983, Region-specific initiation of mouse mammary tumor virus RNA synthesis by endogenous RNA polymerase II in preparation of cell nuclei, J Biol Chem, 258, 2802, 10.1016/S0021-9258(18)32789-3 Stebbins, 1995, The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent, J Exp Med, 181, 223, 10.1084/jem.181.1.223 Steimle, 1993, Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome), Cell, 75, 135, 10.1016/S0092-8674(05)80090-X Steimle, 1995, A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome), Genes Dev, 9, 1021, 10.1101/gad.9.9.1021 Strubin, 1984, The complete sequence of the mRNA for the HLA-DR- associated invariant chain reveals a polypeptide with an unusual transmembrane polanty, Embo J, 3, 869, 10.1002/j.1460-2075.1984.tb01898.x Strubin, 1986, Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain, Embo J, 5, 34833488, 10.1002/j.1460-2075.1986.tb04673.x Wang, 1989, Quantitation of mRNA by the polymerase chain reaction, Proc Natl Acad Sci USA, 86, 9717, 10.1073/pnas.86.24.9717 Wikner, 1986, Study of HLA-DR synthesis in cultured human keratinocytes, J Invest Dermatol, 87, 559, 10.1111/1523-1747.ep12455746